151 related articles for article (PubMed ID: 2523002)
1. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.
Wainwright RB; McMahon BJ; Bulkow LR; Hall DB; Fitzgerald MA; Harpster AP; Hadler SC; Lanier AP; Heyward WL
JAMA; 1989 Apr; 261(16):2362-6. PubMed ID: 2523002
[TBL] [Abstract][Full Text] [Related]
2. The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions.
Heyward WL; Bender TR; McMahon BJ; Hall DB; Francis DP; Lanier AP; Alward WL; Ahtone JL; Murphy BL; Maynard JE
Am J Epidemiol; 1985 Jun; 121(6):914-23. PubMed ID: 3160233
[TBL] [Abstract][Full Text] [Related]
3. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results.
Wainwright RB; McMahon BJ; Bulkow LR; Parkinson AJ; Harpster AP
Arch Intern Med; 1991 Aug; 151(8):1634-6. PubMed ID: 1831343
[TBL] [Abstract][Full Text] [Related]
4. Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study.
Wainwright RB; Bulkow LR; Parkinson AJ; Zanis C; McMahon BJ
J Infect Dis; 1997 Mar; 175(3):674-7. PubMed ID: 9041341
[TBL] [Abstract][Full Text] [Related]
5. Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects.
McMahon BJ; Wainwright K; Bulkow L; Parkinson AJ; Lindenbaum M; Wainwright R; Helminiak C
Am J Med; 1990 May; 88(5):460-4. PubMed ID: 2140010
[TBL] [Abstract][Full Text] [Related]
6. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men.
Hadler SC; Francis DP; Maynard JE; Thompson SE; Judson FN; Echenberg DF; Ostrow DG; O'Malley PM; Penley KA; Altman NL
N Engl J Med; 1986 Jul; 315(4):209-14. PubMed ID: 2941687
[TBL] [Abstract][Full Text] [Related]
7. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis in Eskimos living in an area hyperendemic for hepatitis B.
McMahon BJ; Bender TR; Templin DW; Maynard JE; Barrett DH; Berquist KR; Lum MK; Mann CC
JAMA; 1980 Nov; 244(19):2180-2. PubMed ID: 7420721
[TBL] [Abstract][Full Text] [Related]
10. The control of hepatitis B virus infection with vaccine in Japanese nursery schools.
Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H
Am J Epidemiol; 1987 Sep; 126(3):474-9. PubMed ID: 2956878
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up.
McMahon BJ; Heyward WL; Templin DW; Clement D; Lanier AP
Hepatology; 1989 Jan; 9(1):97-101. PubMed ID: 2562798
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B in selected Alaskan Eskimo villages.
Schreeder MT; Bender TR; McMahon BJ; Moser MR; Murphy BL; Sheller MJ; Heyward WL; Hall DB; Maynard JE
Am J Epidemiol; 1983 Oct; 118(4):543-9. PubMed ID: 6637981
[TBL] [Abstract][Full Text] [Related]
13. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates.
Ding L; Zhang M; Wang Y; Zhou S; Kong W; Smego RA
Clin Infect Dis; 1993 Sep; 17(3):475-9. PubMed ID: 8218692
[TBL] [Abstract][Full Text] [Related]
14. Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results.
Ayoola EA; Atoba MA; Johnson AO
Arch Virol; 1986; 91(3-4):291-6. PubMed ID: 2946277
[TBL] [Abstract][Full Text] [Related]
15. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.
Dentinger CM; McMahon BJ; Butler JC; Dunaway CE; Zanis CL; Bulkow LR; Bruden DL; Nainan OV; Khristova ML; Hennessy TW; Parkinson AJ
Pediatr Infect Dis J; 2005 Sep; 24(9):786-92. PubMed ID: 16148845
[TBL] [Abstract][Full Text] [Related]
16. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
[TBL] [Abstract][Full Text] [Related]
17. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
Lo KJ; Tsai YT; Lee SD; Wu TC; Wang JY; Chen GH; Yeh CL; Chiang BN; Yeh SH; Goudeau A
J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
[TBL] [Abstract][Full Text] [Related]
18. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
McMahon BJ; Bruden DL; Petersen KM; Bulkow LR; Parkinson AJ; Nainan O; Khristova M; Zanis C; Peters H; Margolis HS
Ann Intern Med; 2005 Mar; 142(5):333-41. PubMed ID: 15738452
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, Egypt.
Salama I; Sami S; Saleh R; Mohsen A; Elserougy S; Emam H; Said Z
J Egypt Public Health Assoc; 2017 Jun; 92(2):77-85. PubMed ID: 30184404
[TBL] [Abstract][Full Text] [Related]
20. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.
McMahon BJ; Alward WL; Hall DB; Heyward WL; Bender TR; Francis DP; Maynard JE
J Infect Dis; 1985 Apr; 151(4):599-603. PubMed ID: 3973412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
